BIIB Took a little short AH when it's PDUFA decision was mixed
Shorted at 261.50
Closed out AH at 260.87
Not expecting more than a hamburger and fries. BIOGEN INC is huge company and hard to move its dial.
Well Biib and Esaly look to be joined at the hip. And here I thought they were two profitable independent companies. Amazing how they have traded virtually identical as if this is their only ticket left to punch.
And why no run up? Is the gig finally up Mc? Maybe their MM “cried wolf” one too many times.
Who wants to be the lead Buffalo today?
Can you stampede the herd of bio thieves over the $30Billion dollar cliff for the fourth time? Maybe! But you are stealing from treatments and patients and all those who love them.. for nothing..
The best aduscam will ever be is an adjuvant to anavex or cassava..
Don’t do it again .. even if you can..
Funds swapping spit again, nothing new.
Imagine if fda had denied?
Pyrrhic Victory defined
Amen MC. Im surprised at only a 3.5% rise in pps. Wheres the 10-20 billion MC increase enthusiasm like 4 times before? Maybe they will have to PR it again in a week so the market “gets it”.
Investors can make a difference as to what our healthcare system becomes..
You and your decisions affect millions of lives..
Let Blarcamesine , succesful TLD ,
Be the rule of the day for our sick..
See if other drugs help people once their homeostasis is secured..maybe in smaller doses as an adjuvant ..
Anavex’s Blarcamesine works
If you will give a healthy 5 year old an experimental mRNA drug which creates toxic spike proteins in their system..by design! Nonetheless, why wouldn’t you give death sentenced dementia patients a dangerous possibly brain swelling drug that does almost nothing?
The system is broken
What a scam! Older article but will take afew years to play out Im sure.
Biogen Accused of Baiting Patients With Illegal Drug Co-Pays
September 24, 2021, 9:57 PM EDT
Biogen Inc. was accused by a managed-care provider of illegally boosting sales of its pricey multiple sclerosis drugs by providing them free to patients on a temporary basis and then funneling money to them for co-payments so they can keep taking the medications.
The first part of the scheme involves “seeding” the drugs -- Tysabri, Avonex, and Tecfidera -- to multiple sclerosis sufferers who lacked medical insurance, according to the lawsuit filed Friday by Humana Inc.
After a few months, Biogen encourages the patients to sign up for government-funded healthcare and then funnels “illegal copayment assistance to those same patients under the guise of unrestricted charitable giving,” Humana said.
The money is funneled through a large specialty pharmacy and two medical charities who provide co-pay assistance, according to the suit.
“Given the high costs of the MS drugs here, copays can be thousands of dollars for any single patient,” Humana says in the suit.“But they are a tiny fraction of the total expense for the drugs. This means that if the manufacturer pays the copays itself, it can earn a major return from a minor investment.”
The drugs cost $50,000 to $80,000 a year, according to the suit.
Biogen didn’t respond after regular business hours to a request for comment.
Unlike the patients heads, the share price “swelling” for Biogen always goes down. Another difference is Biogens Alzheimer’s amyloid platform never dies, just a few of their patients here and there in their trials.
Alzheimer’s is tough, didnt you know, just a little collateral damage, now hurry up and give me approval!
Wouldnt touch bioscam
But agree seller salmoat out
Biogen (NASDAQ:BIIB) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $265.00 price target on the stock, up previously from $235.00.This represents a 23.7% upside from the current price of $214.28
---- Biotechs are due for a run soon....jmo
Thought they were getting bought out today?
What’s worse is
They knew who anavex was and blew up a chance at a deep relationship through what appears to be a poorly handled MTA ..
Still waiting for Wayne State.. pathetic really..
Arrogance and power smell worse than week old sub Saharan carrion..
Another pump and dump, this time on approval of their drug of all things! Wow, when even approval doesnt work there is some real bad mojo working against you. 3rd or 4 rth cycle of 20 billion that has come and gone. The HFs that own BIIB are making a killing, no pun intended!
Halberd Corp eradicates (for virtually 100%) the main building block (P-TAU) of ALZHEIMER'S DISEASE from CSF in fully patented extracorporeal treatment, experimentation at ASU and YSU. Same treatment applies to Tau, Beta-Amyloid and the inflammatory cytokines IL-6, TNF-alpha and so on
Laughable, the pps is one step away from giving up all the fake gains from the announcement of Fda approval for their drug which is still not shown to be efficacious and can be highly toxic for patients including but not limited to death.
OAN Im a little surprised that ihub only allows investors to go back 1 year on the charting….. what gives? Those that forget history are more likely to repeat it. Case in point, I was trying to go back 5 years and look at how Biogen has been overhyped now 3 times for the very close to the exact same amount and has given it all back 2 of the 3 and soon to be 3 for 3 times.
Just an observation.
STAT+: Expert panel votes unanimously that Biogen Alzheimer’s drug doesn’t offer patient benefits
By Ed Silverman
The 15-to-0 vote on the Alzheimer's drug Aduhelm amounted to a rebuke of both Biogen and the Food and Drug Administration.
This company's lack of evidence for it's drug' safety and effectiveness should plunge the stock to nothing I wonder what s keeping it on the 300 hundreds. Everyday's bad news around then and it keeps going up ?
It doesntcome close to Anavex results.
CLOSED EXTREMELY BULLISH INTO close and afterhours. I wouldnt wanna be a short tomorrow.
Listen to a $BIIB patient who's A DOCTOR! MUST WATCH VIDEO. DRUG WORKS! Poor shorts lost their ONLY ammo to bash it. Their KEY bash has expired, now they're reaching for anything. $BIIB can run for a full week+ shorts will lose houses here. Will run $600+.
I am not a short seller and hold no short position in this stock..I have no idea what your background is..I am a healthcare professional an MD with a interest in the history of medicine..
The history of medicine was framed nicely by an old professor of mine..
"In medicine the questions don't change only the answers."
Medical science has advanced by errors and misconceptions which continue until this very day, Ambrose Pare was a French "Barber Surgeon" in the middle ages..In his time gunshot wounds of the legs were treated by immersing the amputation stump in boiling oil..The rationale was not (as some of my comrade surgeons imagine) to stop the bleeding..Bleeding from the major leg vessels required tying off the vessels then as is still the case. The boiling oil emersion was done because the thinking in those days that gun powder was toxic and cause tetanus and gangrene. The oil imersion was done after the vessels were ligate and the bleeding stopped. Pare was fairly busy one day and performed 21 amputations. Later he was told they had no available boiling oil. Pare went to bed that night with a heavy heart.he was convinced all his patients would be dead in the morning. To his surprise he found his patients were doing better than usual, Usual being temperatures of 105 degrees.. He thought it was a miracle..
In 1934 the Nobel Prize in medicine was awarded to Minot and Murphy for discovering the treatment of Pernicious Anemia (rampant in the early 20thcentury). Minot and Murphy were awarded the prize by identifying Folic Acid as the deficiency in PA...Turns out Folic Acid deficiency was not the cause of PA, Later on William Castle(one of my professors) proved the true cause was Vit B12...Castle never got the Nobel Prize. These stories are rampant in the history of medicine...Yes we see tangles in AD..but what do they mean and how does it work?...
AD is a disease relating to aging..To my way of thinking most every condition seen in aging is related to the degree of systemic inflammation..The higher your basal inflammatory levels are, the faster you age and I do not see AZ as an outlier..Want to slow down AD..cut down on your systemic inflammation.
Quote..." The causes are known...Check Anavex studies and chromatin structures.."
Take it up with Eli Lilly
The causes are known
Check Anavex studies and chromatin structures
Biogen Idec Inc., a biotechnology company, develops, manufactures, and commercializes novel therapeutics in the areas of neurology, oncology, immunology, cardiopulmonary, and hemophilia in the United States and internationally. The company?s marketed products include AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, low-grade or follicular, CD20-positive, and B-cell Non-Hodgkin?s Lymphoma (NHL); TYSABRI to treat relapsing MS; and FUMADERM for the treatment of severe psoriasis. Its products under development consist of BG-12, a Phase III clinical trial product for the treatment of MS; Humanized Anti-CD20 MAb, a Phase III clinical trial product for the treatment of rheumatoid arthritis and lupus nephritis; Lixivaptan, a Phase III clinical drug for the treatment of Hyponatremia; Daclizumab, a Phase II monoclonal antibody that is being tested in relapsing MS; and Fampridine, an oral compound as a treatment to improve walking ability in people with MS. The company?s products under preclinical stage comprise BIIB014, Ocrelizumab, Neublastin, LINGO, and BART for neurology; Hsp90 Inhibitor, GA101, Anti-IGF-1R, Volociximab, Anti-CRIPTO, RAF Inhibitor, and Anti-Fn14 for oncology; Anti-TWEAK, Anti-CD40L Fab, and Anti-FcRn for immunology; and Long-acting rFactor VIII for hemophilia. It has collaboration agreements with Neurimmune SubOne AG; Cardiokine Biopharma LLC; UCB, S.A.; Swedish Orphan Biovitrum AB; Facet Biotech Corporation; Vernalis plc; and Schering AG. The company was founded in 1985 and is based in Cambridge, Massachusetts.